Developer docs
API playgroundTry for free, no card

Search company profiles

OpSens Medical

Full company profile

uuid002q5t6

Namestring
OpSens Medical
Websiteurl
opsensmedical.com
Company typeenum
Private
Founded yearint
2003
Descriptiontext

OpSens Medical is a for-profit private company headquartered in Quebec, Canada, that develops fiber optic sensors with applications in interventional cardiology and industrial markets. The company was founded in 2003 and operates with 101–250 employees, indicating a specialized medical technology firm of moderate scale that has been continuously commercial for over two decades. Its core products include the OptoWire and SavvyWire, which are fiber optic sensing devices used in interventional cardiology procedures.

The company's technology centers on fiber optic sensing, a modality that uses light-based measurement rather than conventional electrical transducers, enabling high-precision physiological measurements in the cardiac catheterization lab and in industrial process-monitoring environments. The dual-market footprint in medical and industrial applications indicates a technology-platform approach rather than a single-vertical product company, with the same underlying fiber optic measurement capability repurposed across end markets.

OpSens Medical's business model and revenue mechanics are not disclosed in the available data — no pricing structure, distribution channels, or specific customer segments have been documented. The company appears to commercialize through a medical device sales motion typical of interventional cardiology suppliers, but the available source material does not substantiate specific go-to-market details, ownership structure, parent company relationships, or any funding history.

Short descriptiontext

OpSens Medical, founded in 2003 in Quebec, Canada, develops fiber optic sensors for interventional cardiology and industrial applications, including the OptoWire and SavvyWire products. The 101–250 employee company serves medical and industrial sensing markets.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersQuebec, Canada
HQ citystring
Quebec
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
fiber optic sensors, interventional cardiology devices, pressure guidewires, medical fiber optics, industrial fiber optic sensing
Industry1 code
1Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)
CodeHLAHAFALPrimaryYes
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Optical Instruments & Lenses3827
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Devices - Fiber Optic Pressure Sensors
Social media profiles1 record
Cost components5 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

OpSens Medical develops and supplies fiber optic sensors for interventional cardiology and industrial applications. Its portfolio includes the OptoWire and SavvyWire fiber optic-based products used to measure pressure in clinical and industrial settings. The company operates as a device manufacturer serving business customers in healthcare and industrial markets.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1OptoWire
CategoryInterventional Cardiology Devices
Description

Fiber optic pressure guidewire used in interventional cardiology for physiological lesion assessment, enabling intracoronary pressure measurement during diagnostic and therapeutic procedures.

2SavvyWire
CategoryFiber Optic Sensing Devices
Description

Fiber optic sensor product in OpSens Medical's portfolio, referenced alongside OptoWire as part of the company's fiber optic sensing offerings for interventional cardiology and related applications.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
1ACIST Medical Systems
TypeDirect peer
Description

Bracco-owned interventional cardiology company selling FFR and contrast-management products. Direct niche competitor to OpSens in physiology-guided PCI in the cath lab.

2CathWorks
TypeEmerging player
Description

Israel-based developer of the FFRangio system, which computes FFR from routine angiography without an invasive pressure wire. A direct substitute technology to OpSens' OptoWire if angiography-based FFR achieves guideline and payer adoption.

3Boston Scientific
TypeBroad incumbent
Description

Global interventional cardiology player with physiology and structural heart products. Overlaps with OpSens in FFR guidewires and increasingly in TAVR/LAAC workflows where SavvyWire is positioned.

4Philips
TypeBroad incumbent
Description

Sells intravascular imaging (IVUS, iFR/FFR co-registration via SyncVision) used alongside physiology assessment. Comparable to OpSens as a cath-lab physiology/imaging competitor with significantly larger scale.

5Medtronic
TypeBroad incumbent
Description

Broad-line cardiovascular and structural heart medtech with coronary and TAVR franchises. Overlaps with OpSens' cardiology sensor opportunities through its integrated cath-lab offerings.

6GE HealthCare
TypeBroad incumbent
Description

Large imaging and interventional equipment vendor with cath-lab and cardiology offerings. Comparable as a broad incumbent competing for the same hospital capital and per-procedure physiology/imaging budgets.

7Edwards Lifesciences
TypeBroad incumbent
Description

Dominant structural heart player, particularly in TAVR. Comparable to OpSens because SavvyWire is used inside Edwards' core TAVR procedures; Edwards is both a potential channel partner and a long-term competitive threat.

8HeartFlow
TypeEmerging player
Description

Pioneer of non-invasive CT-derived FFR (FFR-CT) for diagnosing coronary disease. Competes with OpSens at the diagnostic workflow level by potentially reducing the need for invasive FFR measurement.

9Opsens Inc.
TypeOthers
Description

Public parent/affiliate of OpSens Medical that historically reported consolidated financials including the medical and industrial fiber optic sensing businesses. Relevant for capital structure context and as the listed entity aggregating OpSens Medical's economics.

10Abbott
TypeBroad incumbent
Description

Major cardiovascular device incumbent selling the PressureWire FFR guidewire and a full cath-lab portfolio. Directly competes with OpSens in physiology-guided PCI while bundling guidewires with imaging, stents, and balloons.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OpSens Medical

Medical Devices - Fiber Optic Pressure Sensorsopsensmedical.com

OpSens Medical, founded in 2003 in Quebec, Canada, develops fiber optic sensors for interventional cardiology and industrial applications, including the OptoWire and SavvyWire products. The 101–250 employee company serves medical and industrial sensing markets.

What OpSens Medical does

OpSens Medical is a for-profit private company headquartered in Quebec, Canada, that develops fiber optic sensors with applications in interventional cardiology and industrial markets. The company was founded in 2003 and operates with 101–250 employees, indicating a specialized medical technology firm of moderate scale that has been continuously commercial for over two decades. Its core products include the OptoWire and SavvyWire, which are fiber optic sensing devices used in interventional cardiology procedures.

The company's technology centers on fiber optic sensing, a modality that uses light-based measurement rather than conventional electrical transducers, enabling high-precision physiological measurements in the cardiac catheterization lab and in industrial process-monitoring environments. The dual-market footprint in medical and industrial applications indicates a technology-platform approach rather than a single-vertical product company, with the same underlying fiber optic measurement capability repurposed across end markets.

OpSens Medical's business model and revenue mechanics are not disclosed in the available data — no pricing structure, distribution channels, or specific customer segments have been documented. The company appears to commercialize through a medical device sales motion typical of interventional cardiology suppliers, but the available source material does not substantiate specific go-to-market details, ownership structure, parent company relationships, or any funding history.

OpSens Medical firmographics

Firmographics
Name
OpSens Medical
Website
https://opsensmedical.com
Company type
Private
Founded year
2003
Headcount range
101–250 employees
Short description
OpSens Medical, founded in 2003 in Quebec, Canada, develops fiber optic sensors for interventional cardiology and industrial applications, including the OptoWire and SavvyWire products. The 101–250 employee company serves medical and industrial sensing markets.
Ownership category
akta.pro rank

OpSens Medical industry classification

Industry
Product category
Medical Devices - Fiber Optic Pressure Sensors
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)

Keywords

  • Fiber optic sensors
  • Interventional cardiology devices
  • Pressure guidewires
  • Medical fiber optics
  • Industrial fiber optic sensing

Where OpSens Medical is headquartered

Location

Headquarters

HQ city
Quebec
HQ country
Canada
HQ region
North America

Markets served

OpSens Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

OpSens Medical product offering

Product offering

Core offering

OpSens Medical develops and supplies fiber optic sensors for interventional cardiology and industrial applications. Its portfolio includes the OptoWire and SavvyWire fiber optic-based products used to measure pressure in clinical and industrial settings. The company operates as a device manufacturer serving business customers in healthcare and industrial markets.

Differentiator

Problem solved

Functional benefit

Products and services

  • OptoWire Fiber optic pressure guidewire used in interventional cardiology for physiological lesion assessment, enabling intracoronary pressure measurement during diagnostic and therapeutic procedures.
  • SavvyWire Fiber optic sensor product in OpSens Medical's portfolio, referenced alongside OptoWire as part of the company's fiber optic sensing offerings for interventional cardiology and related applications.

Companies that use OpSens Medical

Customer profile

Ideal customer profiles2 records

OpSens Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

OpSens Medical partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

OpSens Medical competitors and assessment

Company assessment

Direct peers

  • ACIST Medical Systems: Bracco-owned interventional cardiology company selling FFR and contrast-management products. Direct niche competitor to OpSens in physiology-guided PCI in the cath lab.

Emerging players

  • CathWorks: Israel-based developer of the FFRangio system, which computes FFR from routine angiography without an invasive pressure wire. A direct substitute technology to OpSens' OptoWire if angiography-based FFR achieves guideline and payer adoption.
  • HeartFlow: Pioneer of non-invasive CT-derived FFR (FFR-CT) for diagnosing coronary disease. Competes with OpSens at the diagnostic workflow level by potentially reducing the need for invasive FFR measurement.

Broad incumbents

  • Boston Scientific: Global interventional cardiology player with physiology and structural heart products. Overlaps with OpSens in FFR guidewires and increasingly in TAVR/LAAC workflows where SavvyWire is positioned.
  • Philips: Sells intravascular imaging (IVUS, iFR/FFR co-registration via SyncVision) used alongside physiology assessment. Comparable to OpSens as a cath-lab physiology/imaging competitor with significantly larger scale.
  • Medtronic: Broad-line cardiovascular and structural heart medtech with coronary and TAVR franchises. Overlaps with OpSens' cardiology sensor opportunities through its integrated cath-lab offerings.
  • GE HealthCare: Large imaging and interventional equipment vendor with cath-lab and cardiology offerings. Comparable as a broad incumbent competing for the same hospital capital and per-procedure physiology/imaging budgets.
  • Edwards Lifesciences: Dominant structural heart player, particularly in TAVR. Comparable to OpSens because SavvyWire is used inside Edwards' core TAVR procedures; Edwards is both a potential channel partner and a long-term competitive threat.
  • Abbott: Major cardiovascular device incumbent selling the PressureWire FFR guidewire and a full cath-lab portfolio. Directly competes with OpSens in physiology-guided PCI while bundling guidewires with imaging, stents, and balloons.

Others

  • Opsens Inc. Public parent/affiliate of OpSens Medical that historically reported consolidated financials including the medical and industrial fiber optic sensing businesses. Relevant for capital structure context and as the listed entity aggregating OpSens Medical's economics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights4 records

Customer concentration

OpSens Medical social profiles

Digital presence

OpSens Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OpSens Medical leadership team

Management profile

Number of profiles

OpSens Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OpSens Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OpSens Medical

What does OpSens Medical do?

OpSens Medical develops and supplies fiber optic sensors for interventional cardiology and industrial applications. Its portfolio includes the OptoWire and SavvyWire fiber optic-based products used to measure pressure in clinical and industrial settings. The company operates as a device manufacturer serving business customers in healthcare and industrial markets.

When was OpSens Medical founded?

OpSens Medical was founded in 2003. It employs 101 to 250 people.

Where is OpSens Medical based?

OpSens Medical is headquartered in Quebec, Canada, in the North America region.

Who are OpSens Medical's main competitors?

ACIST Medical Systems is listed as a direct peer. Emerging players are CathWorks and HeartFlow. Broad incumbents are Boston Scientific, Philips, Medtronic, GE HealthCare, Edwards Lifesciences and Abbott. Opsens Inc. is listed as an others.

Does OpSens Medical have an API?

No public API is recorded for OpSens Medical.

What industry is OpSens Medical in?

OpSens Medical's product category is Medical Devices - Fiber Optic Pressure Sensors. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
JaccBeyond Valve Deployment: Real-Time Hemodynamic Optimization During the Double-Tap Technique in TAVRA commentary in JACC: Case Reports discusses a study by Nishimura et al demonstrating that the double-tap technique during transcatheter aortic valve replacement (TAVR) significantly reduces transvalvular gradients and improves hemodynamics. The study, which utilized Edwards Lifesciences valves and OpSens Medical pressure-sensing guidewires, found an immediate mean gradient reduction of 6.5 mm Hg without adverse events. This suggests that integrating real-time invasive hemodynamic assessment can optimize valve expansion beyond standard imaging techniques.PR NewswireHaemonetics Corporation Completes Acquisition of OpSens Inc.Haemonetics completed its acquisition of OpSens, paying CAD $2.90 per share for a fully diluted equity value of about $255 million. The deal adds OpSens' optical cardiology products, including the SavvyWire and OptoWire, and Haemonetics raised its FY2024 revenue growth guidance to 8-10%. OpSens is expected to contribute $55-65 million in revenue in FY2025.DAICResults of SAFE-TAVI Clinical Study Anticipated at TCT 2023OpSens will present results of the SAFE-TAVI clinical study at TCT 2023 on October 25. The study enrolled 119 patients across nine hospitals in Spain and Canada, evaluating the SavvyWire sensor-guided TAVI solution. The company also announced a satellite program on the same day.Cardiovascular BusinessHaemonetics to acquire medical device company known for its TAVR guidewires for $253MHaemonetics agreed to acquire Canadian device maker OpSens for about $253 million. OpSens makes SavvyWire and OptoWire guidewires for TAVR procedures. The deal aims to expand Haemonetics' hospital portfolio and make SavvyWire the top TAVR guidewire in the U.S.MedTech DiveHaemonetics inks $253M OpSens buyout, adding cardiology guidewires to portfolioHaemonetics agreed to buy interventional cardiology firm OpSens for about $253 million. OpSens' pressure-sensing guidewires generated C$34.2 million ($25.2 million) in sales over the first nine months of its fiscal year. The acquisition complements Haemonetics' vascular closure products, with analysts citing a ~$1B market opportunity.BetaKitBoston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CADHaemonetics acquired OpSens in an all-cash deal worth $345 million CAD, paying $2.90 per share. The acquisition, completed on December 12, 2023, gives OpSens a global sales channel, and Haemonetics expects to close the deal by end of January 2024.MassDeviceHaemonetics to acquire OpSens for more than $250M, expanding cardiology device portfolioHaemonetics agreed to acquire cardiology developer OpSens for $253 million in an all-cash deal, expected to close by January 2024. The purchase adds OpSens' optical sensor technology to Haemonetics' hospital business unit, expanding its interventional cardiology portfolio. The deal is expected to be immediately accretive to revenue and adjusted earnings per diluted share.PR NewswireHaemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.Haemonetics Corporation has entered into a definitive agreement to acquire OpSens, Inc. in an all-cash transaction valued at approximately USD $253 million. This acquisition expands Haemonetics' Hospital portfolio by integrating OpSens' fiber optic sensor technology for interventional cardiology procedures such as TAVR and PCI. The deal is expected to close by the end of January 2024, pending shareholder and regulatory approvals.HmpgloballearningnetworkHaemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.Haemonetics Corporation has entered into a definitive agreement to acquire OpSens, Inc. for approximately USD $253 million in an all-cash transaction valued at CAD $2.90 per share. The acquisition expands Haemonetics' hospital portfolio with OpSens' fiber optic sensor technology for interventional cardiology and is expected to close by the end of January 2024.DAICOpSens Announces FDA Clearance for the SavvyWire for Use in Transcatheter Aortic Valve Replacement (TAVR) ProceduresOpSens Inc. received FDA 510(k) clearance for its SavvyWire guidewire for TAVR procedures, announced at TCT 2022. The device is the first sensor-guided TAVR solution, offering hemodynamic measurements and left ventricular pacing without adjunct devices. A limited market release to physician thought-leaders is planned.